To cite this paper use one of the standards below:
The high therapeutic failure rate in chronic Chagas disease might be related to low distribution of benznidazole in the infected tissues by Trypanosoma cruzi. To date, there are no data regarding benzindazole tissue penetration in Chagas disease experimental models. Therefore, this study aimed to investigate the biodistribution of benznidazole in female Swiss mice chronically infected with Berenice-78 strain of Trypanosoma cruzi. After single oral dose of benznidazole 100 mg/Kg to mice (n=40), samples of brain, colon and heart were collected at intervals up to 12 hours (CEUA/UFOP nº 2016/58). Benznidazole tissues concentrations were measured using HPLC-DAD. The one-compartmental pharmacokinetics analyses showed that the brain was the organ with lowest exposure and peak concentration, followed by heart and colon. Benznidazole biodistribution was wide, with very low penetration ratios. These results indicate that the low tissue distribution of benznidazole could be a limiting factor in efficacy of Chagas disease treatment.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper